Cita APA

Avilés-Olmos, I. (., Espinoza-Vinces, C. (., Rogel-Portugal, L. (., & Luquin-Piudo, M. (. R. (2025). Targeting Metabolic Dysfunction in Parkinson’s Disease: The Role of GLP-1 Agonists in Body Weight Regulation and Neuroprotection.

Citación estilo Chicago

Avilés-Olmos, I. (Iciar)|||/items/4c1cd688-4dac-40b2-be8a-a1c8c75468bf, C. (Christian)|||/items/463b0ab0-d175-461c-9bef-58f6e22af1ad Espinoza-Vinces, L. (Leyre)|||/items/bc2e8053-a09a-457b-b36d-b582a4a907c1 Rogel-Portugal, y M.R. (María Rosario)|||/items/6449c359-8b33-4ca4-9ff1-ca1505be7ed3 Luquin-Piudo. Targeting Metabolic Dysfunction in Parkinson’s Disease: The Role of GLP-1 Agonists in Body Weight Regulation and Neuroprotection. 2025.

Cita MLA

Avilés-Olmos, I. (Iciar)|||/items/4c1cd688-4dac-40b2-be8a-a1c8c75468bf, C. (Christian)|||/items/463b0ab0-d175-461c-9bef-58f6e22af1ad Espinoza-Vinces, L. (Leyre)|||/items/bc2e8053-a09a-457b-b36d-b582a4a907c1 Rogel-Portugal, y M.R. (María Rosario)|||/items/6449c359-8b33-4ca4-9ff1-ca1505be7ed3 Luquin-Piudo. Targeting Metabolic Dysfunction in Parkinson’s Disease: The Role of GLP-1 Agonists in Body Weight Regulation and Neuroprotection. 2025.